КЛИНИЧЕСКИЕ И ПРОГНОСТИЧЕСКИЕ АСПЕКТЫ МИКРОАЛЬБУМИНУРИИ У ЖИТЕЛЕЙ ГОРОДА ТВЕРИ
https://doi.org/10.20514/2226-6704-2014-0-6-30-33
Abstract
Aim of study — to evaluate prevalence of microalbuminuria and its correlation with other risk factors of cardiovascular diseases in Tver. Study was done as a part of regional program of prophylaxis of chronic renal failure. From 150 patients we analyzed: anamnesis, BMI, blood pressure. For all patients we perform test for microalbuminuria (test strips MicroAlbuphan). In 45 patients (30%) creatinine in blood and GFR (Cocraft–Goldt) were measured. Analysis of microalbuminuria allows to reveal patients with risk of cardiovascular diseases. We reveal correlation of microalbuminuria with diabetes mellitus, duration of arterial hypertension, duration of smoking, obesity, GFR. More then 1⁄2 patients demonstrate chronic renal disease of 2 stage. It is very important in case it was found at out-patient department.
About the Author
О. Б. Поселюгина
ГБОУ ВПО «Тверская государственная медицинская академия», кафедра госпитальной терапии и профессиональных болезней, г. Тверь
Russian Federation
Russian Federation
References
1. American diabetes association: standards of medical care in diabetes // 2008. Diabetes Care. 2008. Vol. 31 (Suppl. 1). S12–S54.
2. British hypertension society guidelines (BHS-IV) // J. Fam. Pract. 2004. Vol. 53. P. 528–550.
3. Gerstein H.C., Mann J.F., Yi Q. et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals // JAMA. 2001. Vol. 286. P. 421–426.
4. Karalliedde J., Viberti G. Microalbuminuria and cardiovascular risk // Am. J. Hypertens. 2004.; Vol. 17. P. 986-993.
5. Mancia G., De Backer G., Dominiczak A. et al. Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) // J. Hypertens. 2007. Vol. 25. P. 1105–1187.
6. National clinical guidelines. GFCF. Moscow, 2010. 592 p. (Национальные клинические рекомендации. ВНОК. Москва, 2010. 592 с.).
7. Pedrinelli R., Dell’Omo G., Di Bello V. et al. Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension // J. Hum. Hypertens. 2002. Vol. 16. P. 79–89.
8. Volpe M. Microalbuminuria screening in patients with hypertension: recommendations for clinical practice // Int. J. Clin. Pract. 2008. Vol. 62. No 1. Р. 97–108.
Review
For citations:
Поселюгина О.Б. КЛИНИЧЕСКИЕ И ПРОГНОСТИЧЕСКИЕ АСПЕКТЫ МИКРОАЛЬБУМИНУРИИ У ЖИТЕЛЕЙ ГОРОДА ТВЕРИ. The Russian Archives of Internal Medicine. 2014;(6):30-33. (In Russ.) https://doi.org/10.20514/2226-6704-2014-0-6-30-33
Views:
720
Email this article 